Over a median follow-up period of 61 months, 27 patients (42.1%) harboring high ZFAND4 expression in undifferentiated cells calculated by using the mean Allred score died due to the index cancer, and 15 patients (41.6%) with high ZFAND4 expression in the differentiated cells. Here, ZFAND4 is linked to cancer.